Entry level $345 = Target price $375 = Stop loss $336
Bullish reversal occurring in regenerson after quite a sustained correction.
Historical buy signal is complete on the weekly chart, the daily chart is a little overbought so we await a break in the weekly RSI for a safer entry.
Average analysts price target $383 | Overweight.
P/E ratio 18.78.
Company profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
Bullish reversal occurring in regenerson after quite a sustained correction.
Historical buy signal is complete on the weekly chart, the daily chart is a little overbought so we await a break in the weekly RSI for a safer entry.
Average analysts price target $383 | Overweight.
P/E ratio 18.78.
Company profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.